FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Diabeloop Receives CE Mark for Blood Sugar Monitoring Technology

Nov. 15, 2018

Diabeloop’s DBLG1 technology for monitoring and maintaining blood sugar levels has earned the CE Mark.

The self-learning, customizable system can mimic the pancreas’ insulin-dispensing functions and adapt to the patient.

The DBLG1 links to a continuous blood glucose monitoring system and an insulin patch pump to predict glucose levels and optimally control the pump.

View today's stories